Acta Chimica and Pharmaceutica Indica
ISSN: 2277-288X

CANCER IMMUNOTHERAPY

Cancer immunotherapy (now and again called immuno-oncology) is the counterfeit incitement of the resistant framework to treat malignancy, enhancing the invulnerable framework's normal capacity to battle the ailment. It is an utilization of the key examination of malignancy immunology and a developing subspecialty of oncology. Malignancy immunotherapy misuses the way that disease cells frequently have tumour antigens, particles on their surface that can be recognized by the counter acting agent proteins of the invulnerable framework, official to them. The tumour antigens are regularly proteins or different macromolecules (e.g., sugars). Ordinary antibodies tie to outer pathogens, however the adjusted immunotherapy antibodies tie to the tumour antigens checking and distinguishing the disease cells for the insusceptible framework to restrain or murder.

High Impact List of Articles

Relevant Topics in Chemistry

Awards Nomination

Table of Contents

Google Scholar citation report
Citations : 968

Acta Chimica and Pharmaceutica Indica received 968 citations as per Google Scholar report

Citation image

Indexed In

  • Open J Gate
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Cosmos IF
  • Scientific Indexing Services (SIS)
  • ICMJE

View More

For Authors

For Librarians

Flyer

Open Access Journals